Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -850 | -4,301 | -3,242 | -1,763 | -947 |
| Depreciation Amortization | 50 | 374 | 302 | 238 | 103 |
| Other Working Capital | 495 | 2,540 | 1,870 | 1,125 | 541 |
| Other Operating Activity | 19 | 874 | 720 | 294 | 285 |
| Operating Cash Flow | $-287 | $-513 | $-351 | $-106 | $-18 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 82 | 275 | 60 | 1 | N/A |
| Debt Issued | 98 | 60 | 275 | 90 | 1 |
| Common Stock Issued | 117 | 163 | N/A | N/A | N/A |
| Other Financing Activity | -5 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $291 | $497 | $334 | $91 | $1 |
| Beginning Cash Position | 1 | 17 | 17 | 17 | 17 |
| End Cash Position | 5 | 1 | 0 | 2 | 0 |
| Net Cash Flow | $5 | $-16 | $-17 | $-15 | $-17 |
| Free Cash Flow | |||||
| Operating Cash Flow | -287 | -513 | -351 | -106 | -18 |
| Free Cash Flow | -287 | -513 | -351 | -106 | -18 |